Navigation

Praluent

side effects drug center praluent (alirocumab for solution for subcutaneous injection) drug - patient side effects and images

  • Related Drugs
    Crestor Evkeeza Lovaza Mevacor Pravachol Repatha Rosuvastatin Calcium Simcor Trilipix Vayarol Zetia Zocor
  • Health Resources
    Cholesterol (Lowering Your Cholesterol)
    • Praluent Patient Information Including Side Effects

    Brand Names: Praluent Pen, Praluent Syringe

    Generic Name: alirocumab

    What is alirocumab (Praluent Pen, Praluent Syringe)?

    Alirocumab is used in people with heart disease, to help lower the risk of heart attack, stroke, or needing to be hospitalized because of chest pain (unstable angina).

    Alirocumab is also used to help lower blood levels of LDL cholesterol in people with heterozygous familial hypercholesterolemia (an inherited type of high cholesterol). Alirocumab is used together with a low-fat diet and sometimes in combination with a "statin" medication.

    Alirocumab may also be used for purposes not listed in this medication guide.

    What are the possible side effects of alirocumab (Praluent Pen, Praluent Syringe)?

    Get emergency medical help if you have signs of an allergic reaction: hives, severe itching; difficult breathing; swelling of your face, lips, tongue, or throat.

    Common side effects may include:

    This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

    What is the most important information I should know about alirocumab (Praluent Pen, Praluent Syringe)?

    Follow all directions on your medicine label and package. Tell each of your healthcare providers about all your medical conditions, allergies, and all medicines you use.

    Praluent Patient Information including How Should I Take

    What should I discuss with my healthcare provider before using alirocumab (Praluent Pen, Praluent Syringe)?

    You should not use alirocumab if you are allergic to it.

    It is not known whether this medicine will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant.

    You should not breastfeed while using this medicine.

    Alirocumab is not approved for use by anyone younger than 18 years old.

    How should I use alirocumab (Praluent Pen, Praluent Syringe)?

    Follow all directions on your prescription label and read all medication guides or instruction sheets. Your doctor may occasionally change your dose. Use the medicine exactly as directed.

    Alirocumab is injected under the skin once every 2 to 4 weeks. A healthcare provider may teach you how to properly use the medication by yourself.

    Read and carefully follow any Instructions for Use provided with your medicine. Ask your doctor or pharmacist if you don't understand all instructions.

    If you use alirocumab only once every 4 weeks, you will give yourself 2 separate injections at the same time. Use a new syringe or injection pen for each injection. Give each injection into a different place on your body.

    You may need frequent blood tests.

    Do not shake this medicine. Prepare an injection only when you are ready to give it. Do not use if the medicine has changed colors, or has particles in it. Call your pharmacist for new medicine.

    Store this medicine in the refrigerator, do not freeze. Protect from light and high heat.

    Take the medicine out of the refrigerator and allow it to reach room temperature for 30 to 40 minutes before injecting your dose. Do not heat an injection pen or prefilled syringe, and do not leave the pen at room temperature for longer than 30 days.

    Each injection pen or prefilled syringe is for one use only. Throw it away after one use, even if there is still medicine left inside.

    Use a needle and syringe only once and then place them in a puncture-proof "sharps" container. Follow state or local laws about how to dispose of this container. Keep it out of the reach of children and pets.

    You should not stop using alirocumab without your doctor's advice, or your LDL cholesterol levels may increase.

    Praluent Patient Information including If I Miss a Dose

    What happens if I miss a dose (Praluent Pen, Praluent Syringe)?

    Give an injection within 7 days after the missed dose. Then give the next injection 2 to 4 weeks after the missed dose was due, to put you back on your regular injection schedule.

    If you are more than 7 days late for an injection:

    • If you inject every 2 weeks, skip the missed dose and use your next dose at the regular time.
    • If you inject every 4 weeks, start a new schedule based on the date you used the missed injection.

    Do not use two doses at one time.

    What happens if I overdose (Praluent Pen, Praluent Syringe)?

    Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

    What should I avoid while using alirocumab (Praluent Pen, Praluent Syringe)?

    Do not inject alirocumab into skin that is sunburned, infected, swollen, or otherwise irritated.

    What other drugs will affect alirocumab (Praluent Pen, Praluent Syringe)?

    Other drugs may affect alirocumab, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using.

    Where can I get more information (Praluent Pen, Praluent Syringe)?

    Your pharmacist can provide more information about alirocumab.

    Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.
    Every effort has been made to ensure that the information provided by Cerner Multum, Inc. ('Multum') is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Multum information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Multum does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Multum's drug information does not endorse drugs, diagnose patients or recommend therapy. Multum's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Multum does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Copyright 1996-2021 Cerner Multum, Inc.